Use of CA125 and Complementary Biomarkers for the Early Detection of Ovarian Cancer in Low Risk Women | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Use of CA125 and Complementary Biomarkers for the Early Detection of Ovarian Cancer in Low Risk Women	Adnexal Diseases, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, endocrine system disorder, female reproductive system disorder, female reproductive system neoplasm, gonadal disorder, malignant endocrine neoplasm, neoplasm, ovarian cancer, ovarian disorder	Recruiting	Not applicable	2026-10-09		NCT00539162

3 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Golfers Against Cancer	1
M.D. Anderson Cancer Center	1145
National Cancer Institute (NCI)	3015

12 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Carol G. Simon Cancer Center / Atlantic Health	Morristown	United States	1
John Stoddard Cancer Center	Des Moines	United States	1
Sylvester Comprehensive Cancer Center, Univ of Miami Miller School of Medicine	Miami	United States	1
The University of Texas at Austin	Austin	United States	23
University of Minnesota	Minneapolis	United States	30
University of Oklahoma Health Sciences Center	Oklahoma City	United States	491
University of Rochester Medical Center	Rochester	United States	162
University of Texas (UT) Southwestern Medical Center	Dallas	United States	1
University of Texas MD Anderson Cancer Center	Houston	United States	192
UT Health Science Center San Antonio	San Antonio	United States	2
Women's and Infant's Hospital	Providence	United States	1
Women's Hospital of Texas, Obstetrics and Gynecology Associates (OGA)	Houston	United States	1